Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 38Prostatic Neoplasms 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lung Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Neoplasms 14Leukemia 13Rectal Neoplasms 12Uterine Cervical Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 10Colorectal Neoplasms 10Colonic Neoplasms 10Sarcoma 9Leukemia, Myeloid, Acute 8Central Nervous System Neoplasms 8Brain Neoplasms 8Pain 7Ovarian Neoplasms 7Neuroblastoma 7Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Head and Neck Neoplasms 7Small Cell Lung Carcinoma 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Testicular Neoplasms 5Sezary Syndrome 5

Interventions

Surgical Procedures, Operative 1Etanidazole 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NIH × Glioma, Subependymal × Clear all
NCT00430079 2013-01-16

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

National Cancer Institute (NCI)

Phase NA Terminated
48 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡